Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,681,130
  • Shares Outstanding, K 22,469
  • Annual Sales, $ 883,370 K
  • Annual Income, $ 78,340 K
  • EBIT $ 203 M
  • EBITDA $ 294 M
  • 60-Month Beta 0.52
  • Price/Sales 1.89
  • Price/Cash Flow 7.47
  • Price/Book 3.09

Options Overview Details

View History
  • Implied Volatility 45.26% (-1.65%)
  • Historical Volatility 33.07%
  • IV Percentile 47%
  • IV Rank 31.03%
  • IV High 73.85% on 07/24/25
  • IV Low 32.40% on 09/22/25
  • Expected Move (DTE 28) 10.39 (13.88%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 8
  • Volume Avg (30-Day) 278
  • Put/Call OI Ratio 1.66
  • Today's Open Interest 6,762
  • Open Int (30-Day) 4,700
  • Expected Range 64.43 to 85.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.08
  • Number of Estimates 4
  • High Estimate 1.54
  • Low Estimate 0.77
  • Prior Year 1.37
  • Growth Rate Est. (year over year) -21.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.15 +6.66%
on 03/13/26
78.84 -5.10%
on 02/20/26
-3.28 (-4.20%)
since 02/19/26
3-Month
70.15 +6.66%
on 03/13/26
87.07 -14.07%
on 01/16/26
-8.03 (-9.69%)
since 12/19/25
52-Week
56.71 +31.93%
on 05/23/25
99.50 -24.80%
on 09/10/25
+9.95 (+15.34%)
since 03/19/25

Most Recent Stories

More News
3 Profitable Stocks That Concern Us

3 Profitable Stocks That Concern Us

BK : 114.62 (-0.24%)
ANIP : 74.45 (-0.49%)
QTWO : 47.25 (-2.82%)
Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best

Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best

ANIP : 74.45 (-0.49%)
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

SOLV : 66.40 (-1.10%)
GH : 87.89 (-1.34%)
ALHC : 17.65 (-2.81%)
ANIP : 74.45 (-0.49%)
CLOV : 1.8650 (-1.32%)
ANI: Q4 Earnings Snapshot

ANI: Q4 Earnings Snapshot

ANIP : 74.45 (-0.49%)
ANI Pharmaceuticals (NASDAQ:ANIP) Beats Expectations in Strong Q4 CY2025, Stock Jumps 12.4%

ANI Pharmaceuticals (NASDAQ:ANIP) Beats Expectations in Strong Q4 CY2025, Stock Jumps 12.4%

ANIP : 74.45 (-0.49%)
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance

Record quarterly and full year net revenues of $247.1 million and $883.4 million, up 29.6% and 43.8% year-over-year, respectively Total Rare Disease quarterly and full year net revenue...

ANIP : 74.45 (-0.49%)
ANI Pharmaceuticals to Present at Upcoming Investor Conferences

PRINCETON, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with...

ANIP : 74.45 (-0.49%)
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET

PRINCETON, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its fourth quarter and full year 2025 financial...

ANIP : 74.45 (-0.49%)
1 Safe-and-Steady Stock Worth Your Attention and 2 That Underwhelm

1 Safe-and-Steady Stock Worth Your Attention and 2 That Underwhelm

NNI : 126.65 (-0.81%)
ANIP : 74.45 (-0.49%)
TSCO : 45.92 (-0.56%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

RRR : 58.26 (-2.67%)
ANIP : 74.45 (-0.49%)
BAND : 15.10 (-2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 77.08
2nd Resistance Point 76.29
1st Resistance Point 75.56
Last Price 74.45
1st Support Level 74.04
2nd Support Level 73.25
3rd Support Level 72.52

See More

52-Week High 99.50
Fibonacci 61.8% 83.15
Fibonacci 50% 78.10
Last Price 74.45
Fibonacci 38.2% 73.06
52-Week Low 56.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar